Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PCSA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 4
12 filers reported a long position in PCSA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Connective Capital Management, LLC | $163.7K | 85.3K | +20.6% |
| Stonepine Capital Management, LLC | $105.6K | 55K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $42.4K | 22.1K | -11.3% |
| CITADEL ADVISORS LLC | $40.9K | 21.3K | New |
| StoneX Group Inc. | $29.6K | 11.4K | New |
| XTX Topco Ltd | $25.5K | 13.3K | New |
| JANE STREET GROUP, LLC | $25.5K | 13.3K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.4K | 12.7K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $20.8K | 10.9K | Unchanged |
| UBS Group AG | $15K | 7.8K | +207.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.